Clinical Trials Browser

Phase 2/3 × Interventional × Musculoskeletal Diseases × Clear all

NCT01809171 2015-10-21

Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients

Phase 2/3 Terminated

Breast Neoplasms, Musculoskeletal Diseases